News
Dr. Stephana Julia Moss, an investigator at the Canadian Center for Vaccinology (CCfV), Dalhousie University, has been ...
Identifying good mid cap stocks from hundreds of options is no easy feat. Luckily, we've done the hard work for you.
Investing.com -- Shares of AstraZeneca (ST: AZN) and GlaxoSmithKline (LON: GSK) fell Tuesday after former U.S. President ...
The debate between CAR T-cell therapy and bispecific antibodies is not a rivalry but a question of sequencing, ...
1d
Zacks Investment Research on MSNHere's Why GSK (GSK) is a Strong Momentum StockFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...
GSK plc (NYSE:GSK) is one of the 12 best healthcare stocks to buy now. On June 12, the company announced licensing its ...
GSK PLC closed 11.51% short of its 52-week high of £16.79, which the company achieved on September 9th.
1d
Zacks Investment Research on MSNEMA Accepts GSK's Filing for Expanded Use of RSV Vaccine ArexvyGSK plc GSK announced that the European Medicines Agency (EMA) has accepted the regulatory application seeking approval to ...
GSK plc (LSE/NYSE: GSK) today announced the launch of the Linked by Lupus: Optimal Care Initiative to help support individuals impacted with lupus, particularly systemic lupus erythematosus (SLE) and ...
Sage Therapeutics Inc. has found itself a buyer that bested the unsolicited acquisition offer a few months ago from fellow ...
Recent collaborations highlight a growing interest in building a multiomics-based understanding of health and disease.
GSK PLC GSK shares dropped 2.45% to £15.12 Friday, on what proved to be an all-around poor trading session for the stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results